Effect of intrapartum pethidine on the neonatal outcome: is it duration related? by Abdulwahab, Dalia F et al.
Poster presentations / International Journal of Gynecology & Obstetrics 119S3 (2012) S531–S867 S807
loss, adequate uterine tone, reduction of PPH incidence and severity,
adverse effects and need of additional medications.
Materials: A prospective controlled clinical trial on 216 women
undergoing caesarean section was conducted. All pregnancies were
at term and with at least one risk factor for PPH (multiparity,
multiple pregnancy, previous caesarean section, polyhydramnios,
fetal macrosomia, uterine miomas, placenta praevia, prolonged
labor, chorioamnionitis and previous PPH).
Methods: The effect of a single dose of carbetocin (n =108) and
oxytocin infusion (n =108) were compared with respect to: vital
signs, uterine involution, amount of lochia, serum haemoglobin,
postoperative pain, diuresis, need of analgesic and/or diuretic drugs
and adverse effects. Group comparisons were made using chi-
square tests for categorical and either Student’s t tests or one-way
ANOVA for continuous variables.
Results: Postoperative pain in the day of surgery was significantly
lower (p < 0.05) in women receiving carbetocin than in those on
oxytocin infusion and remained significant until the third day. In
the day of surgery and the day after, the need of analgesic drugs was
significantly lower (p < 0.05) in women receiving carbetocin than
in those on oxytocin infusion. No differences were found regarding
intraoperative blood loss, uterine involution and tone, amount of
lochia, vital signs, serum haemoglobin, adverse effects, diuresis and
need of diuretic drugs.
Conclusions: Carbetocin was efficacious and safe on the
maintenance of uterine tone and limitation of blood loss in women
at risk for PPH, in intra- and postoperative period. Moreover,
carbetocin was able to reduce postoperative pain perception respect
to oxytocin.
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Objectives: To determine the effect of vaginal misoprostol in labour
induction with respect to induction-delivery time interval and fetal-
maternal outcomes in primiparous and not primiparous women.
Materials: 131 women between 15 and 47 years old, assisted
in 2010, with live singleton pregnancy, cephalic presentation,
unfavourable Bishop score and indication for induction of labour.
Methods: Cross sectional study. The patients were divided into 2
groups: primiparous or not. The indications for labour induction
were: (a) maternal (diabetes, hypertensive disorders, prolonged
pregnancy and collagen diseases), (b) fetal (oligohydramnios and
fetal growth restriction) and (c) premature rupture of membranes
(PRM). Vaginal misoprostol 50mcg was given at 4 hours interval,
up to a maximum of 6 doses, until labour was induced.
Statistic analysis was performed using Epi-info3.5.1. The categorical
variables were described as proportions, while continuous variables
were expressed as means and standard deviations, using the Fisher’s
exact test. Fetal-maternal outcomes and induction-delivery time
interval in hours were the main outcome measures. The study was
approved by the Institutional Research Ethics Committee of the
HUPE/UERJ.
Results: The main indications for labour induction in primiparous
women were: maternal (66%), fetal (9%) and PRM (25%). In the non-
primiparous were similar (69%, 5%, 25%) (p = 0.60). The gestational
age at delivery did not differ: 95% (58) of primiparous and 90% (63)
of non-primiparous presented 37 weeks or more (p = 0.08). There
was also no statistic difference concerning the induction-delivery
time interval: 11.7±6.4 and 10.4±6.1 hours in the primiparous and
non-primiparous, respectively (p = 0.13). Induction failure rate was
13% (8) of primiparous and 11.4% (8) of non-primiparous (p = 0.40).
Vaginal birth tended to be more frequent in non-primiparous,
which occurred in 64.3% (45) and in 59% (36) of primiparous
(p = 0.05). It was not observed any difference regarding the Apgar
and the newborns presented Apgar <7 in the 1st minute in 11.3%
(7) and 15.8% (11) (p = 0.28), and in the 5th minute in 1.4% (1) and
1.8% (1) (p = 0.71), respectively.
Conclusions: Vaginal misoprostol showed to be excellent choice
for labour induction, with small failure rates in both groups. There
is no difference between primiparous and non-primiparous women
concerning the induction-delivery time interval and Apgar scores.
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Objectives: To study the effect of pethidine on the intrapartum
fetal heart rate (FHR) pattern and to assess the neonatal outcome
with regards to the interval between pethidine administration to
delivery of the fetus.
Materials: 73 healthy women intrapartum from labour suite
hospital Tengku Ampuan Afzan, Kuantan, Malaysia.
Methods: This is a prospective observational study done on 73
healthy consented women with singleton pregnancy at term. All
fetus were normal, vertex presentation with reactive FHR tracing
before pethidine administration. FHR recording were performed
for 40 minutes prior to and one hour post pethidine. Cervical
dilatation of all patients ≤4 cm at time of pethidine administration.
Intramuscular pethidine 1mg/kg was given as an intrapartum
analgesia. The study sample was divided into two groups, first
group delivered within 4 hours and second group delivered more
than 4 hours after the pethidine administration. The data were
analysed by SSPS 17.0.
Results: the mean age of the recruited patients is 28.15±6.15 years
and mean gestational age of 39.14±1.094 weeks. The mean duration
from pethidine administration to delivery is 296.48±173.65 minutes
(4 hours and 56 minutes). Four (5.5%) cases had suspicious CTG
1 hour post pethidine, 1 with absence of acceleration for 45 minutes
and 3 cases with early deceleration lasted for 60 to 90 minutes. Out
of 73 patients, 38 babies delivered within 4 hours and 35 delivered
after 4 hours of pethidine. All neonates delivered with good Apgar
Score (AS), 8 at 1 minute and 9 at 5 minute except 1 with AS of 5
at 1 min and 7 at 5 min which delivered more than 4 hours after
pethidine. Sixteen (21.9%) cases were admitted to the Neonatal
Intensive Care Unit (NICU). Eleven (68.75%) cases were admitted
due to neonatal sedation from the delivery group less than 4 hours
after pethidine. Five (31.25%) cases from the delivery group more
than 4 hours, 4 cases with a diagnosis of transient tachypnea of
newborn and 1 secondary to meconium aspiration syndrome (MAS).
All discharge to mother after 24 hours, non required ventilation
apart from the one with MAS which required ventilation for one day
and longer admission. Despite of the higher number of those require
admission in the less than 4 hours group, it was not statistically
significant with P value of 7.44.
Conclusions: Pethidine can be used as an intrapartum analgesia
which is safe, easily available without major effect on fetal heart
rate pattern and neonatal outcome even if given in advance stage
of labour.
